Betting big on the Chinese market, Dr. Reddy’s Laboratories has started outsourcing manufacture of some of the drugs to local partners. The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year.
The company is working towards filing and an eventual launch of over 70 products, across the chosen therapy areas, over the next few years. It has 8-10 products currently available in the market. All company’s products are marketed either through its Joint Venture, Kushnan Rotam Reddy Pharmaceuticals (KRRP) or through its partners in China. The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |